You might also read
Articles linked to this work by shared authors, journal, and citation graph.
James F Rusling1,2,3,4, Robert J Forster5,6
1Department of Chemistry, University of Connecticut, Storrs, CT 06269, USA.
Highly sensitive assays are crucial for detecting low-abundance disease biomarkers in complex samples. Innovations in nanomaterials, bioreceptors, and microfluidics are key to advancing early diagnosis and personalized medicine.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: